Advertise Here

New Haven: Three executives from pharma giant Bristol Myers Squibb [NYSE: BMY] are finding new homes at two affiliated New Haven biotech companies. Biohaven [NYSE: BHVN] which went public two months ago with a $168 million IPO has hired two former BMY execs for key leadership positions as the company continues to move forward on developing its diverse portfolio of drugs.

manion
Manion: new CEO at KLEO
stock
Stock:  appointed head of Portfolio Strategy and Development at Biohaven
mcgrath
McGrath: Chief of Corporate Strategy and Business Development, Biohaven.

Elyse Stock, M.D. has been appointed as the company's Chief of Portfolio Strategy and Development, and St. John (Donnie) McGrath, M.D. has been appointed as Chief of Corporate Strategy and Business Development.

Douglas Manion, M.D., FRCP(C), as the new CEO of Kleo Pharmaceuticals. Manion has most recently served as SVP head of specialty development at BMS. Kleo's lead investor is Biohaven.

David Spiegel, M.D., Ph.D. co-founder of Kleo who’s technology is based on the work of his lab at Yale University, was himself appointed CEO this past September soon after the  investment led by Biohaven.

Stock was most Vice-President Global Development Leader at Bristol-Myers Squibb (BMS), where she worked for the last 19 years in various positions “developing numerous investigational agents across multiple therapeutic areas including neuroscience, oncology, immunology and cardiovascular disease.”

McGrath, served as Vice President of Business Development and Head of Search & Evaluation. was responsible for overseeing BMS' venture capital investment portfolio and provided leadership for all global external partnering activities.

immeltBoston:  General Electric's [ NYSE: GE] CEO  Jeff Immelt is stepping down after seventeen years, John Flannery the president and CEO of GE Healthcare, has been named chairman and CEO

Immelt will remain chairman of the board through his retirement from the company on December 31, 2017. Immelt is 61 and GE’s mandatory retirement age is 65.

In 2015 Immelt announced a move of GE’s suburban Fairfield headquarters to Boston. The majority of GE’s employees however did stay in Connecticut, moving more than 600 employees to Norwalk. GE’s Fairfield suburban campus valued by some at more than $75 million was sold to Sacred Heart University for only $35 million. The GE campus is nearly continguous to the Sacred Heart campus. Scared Heart and GE have had a long standing relationship and former CEO Jack Welch donated heavily to the school and it hosts the Jack Welch College of Business.

Dittirich Chris SLAM Neff Rod SLAM
Dittirich Neff

Glastonbury: S/L/A/M Construction Services (SLAM CS) has hired Rod Neff, CHFM, and Chris Dittrich, CDT, as senior project managers.

Neff, a Certified Healthcare Facility Manager (CHFM), brings 30 years of construction industry experience to SLAM CS, including 20 years in the healthcare industry. In his previous position, Neff was the senior project manager for many healthcare projects in Connecticut and Mass.

Dittrich has 13 years of experience working in the construction industry, seven of which have included working for SLAM CS as a project manager and cost estimator.  Dittrich has completed more than 24 new construction and renovation projects in the healthcare, corporate, educational, residential and public markets.

orloff
 John Orloff, New Alexion R&D Head did seven Years at Yale Med School

By Mitchell Young

Key Executive Hires From Hantson's Previous Company, Baxalta

New Haven: What new Alexion [ Nasdaq{: ALXN ]CEO  Ludwig Hantson has in mind in his C Suite makeover has gotten a little more clear. In Early May, the company announced the departure of four key executives, including Martin Mackay, EVP and the head of R&D for the company who will “retire” this year. McKay joined Alexion in 2013 and will be replaced by John Orloff, M.D.

Orloff has most recently been head of R&D at Novelion [Nasdaq: NVLN] a small $175 million market cap rare disease biotech headquartered in Vancouver, B.C. with operations in Cambridge Mass as well.

Before then, Orloff was global head of R&D and CSO [Chief Science Officer] at Baxalta, where he worked for then CEO Hantson.  

 

GNHCC TONY RESCIGNOCHAMBER RELEASE

New Haven, CT (May 22, 2017) – After 17 years of service as the President of the Greater New Haven Chamber of Commerce (GNHCC), Anthony Rescigno announced today his plans to retire on December 31, 2017.  A search committee of Chamber board members and community business leaders has been formed to identify a successor.

“As someone who has been involved in local business affairs for the better part of my career, I am so proud of what we have accomplished over the years,” said Anthony Rescigno, president of the GNHCC. “It has been a true privilege to serve with and for some of the best and brightest in our region and to be blessed with an extraordinary staff throughout my tenure at the Chamber. While I will absolutely miss those interactions every day, I have decided that the time is right for me to retire.”

angelicoMadison: Colliers International | Project Management Northeast (PMNE) announces the addition of Maria Angelico as Marketing & Business Development Manager.

In this role, Angelico is responsible for outbound marketing efforts to grow the Colliers PMNE brand. She will also be involved with business development activities to create new client and project opportunities, in support of the company’s services and sectors throughout New England.

Angelico is an emerging professional who brings a unique background in strategic development from tech start-ups to architectural firms. She joins the Colliers PMNE team with over six years of experience in architecture, marketing, and business development. “As a leader in its industry, Colliers continues to evolve to meet the changing needs of our clients – building relationships and awareness in our markets is essential as we continue to grow,” Angelico stated.